1 – 10 of 19
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Explaining biological depression theories
- Contribution to journal › Letter
-
Mark
Let the drugs lead the way! : On the unfolding of a research programme in psychiatry
- Contribution to journal › Article
- 2017
-
Mark
Functioning Numbness Instead of Feelings as a Direction : Young Adults’ Experiences of Antidepressant Use
- Contribution to journal › Article
- 2016
-
Mark
Living the neurochemical self? : Experiences after the success of the SSRIs
- Contribution to journal › Article
-
Mark
Taking it out on the body? : A phenomenological study of young adults’ gendered experiences of antidepressant use
- Contribution to journal › Article
-
Mark
Tillståndet som förlorade sitt namn men fick en behandling : Erfarenheter av depression och antidepressiva läkemedel i en nyliberal kontext
(2016) p.84-109
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2015
-
Mark
Divergence and convergence of commercial and scientific priorities in drug development: the case of Zelmid, the first SSRI antidepressant
- Contribution to journal › Article
-
Mark
Donna Haraway
(2015) p.207-228
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
New materialism, depression and antidepressants: at the 9th European Feminist Research Conference, Sex & Capital, 3-6 June, 2015, University of Lapland, Rovaniemi, Finland : engaging in feminist dialogues about the body and biology
(2015) The 9th European Feminist Research Conference
- Contribution to conference › Abstract
-
Mark
The condition that lost its name but gained a treatment: : experiences of depression and antidepressant use in a neoliberal context
(2015) 9th European Feminist Research Conference, Sex & Capital
- Contribution to conference › Abstract